Lv3
266 积分 2022-08-09 加入
Pharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer Patients
1个月前
已关闭
BRAF-MUTANT METASTATIC NON–SMALL-CELL LUNG CANCER: REAL WORLD DATA FROM THE ITALIAN BIOMARKER ATLAS DATABASE
1个月前
已完结
Targeting the MAPK Pathway for NRAS Mutant Melanoma: From Mechanism to Clinic
2个月前
已完结
Multimodal treatment with thiotepa, bevacizumab, teniposide, and tunlametinib in a patient with neurofibromatosis type 1-associated oligodendroglioma: a rare case report
2个月前
已完结
Type II RAF inhibitor tovorafenib for the treatment of pediatric low-grade glioma
2个月前
已完结
Tovorafenib: First Approval
2个月前
已完结
Operational characteristics of full random effects modelling (‘frem’) compared to stepwise covariate modelling (‘scm’)
2个月前
已完结
FDA new drug approvals in Q2 2025
2个月前
已完结
FDA approves 100th small-molecule kinase inhibitor
2个月前
已完结
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
2个月前
已完结
皖公网安备34019202002308
